4 Recruiting Acute Myeloid Leukemia Clinical Trials in Connecticut
Explore active acute myeloid leukemia research studies enrolling across Connecticut. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Acute Myeloid Leukemia Studies in Connecticut
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
📍 Smilow Cancer Hospital Care Center at Greenwich — Greenwich, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Revumenib in Combination With 7+3 + Midostaurin in AML
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
📍 Yale-New Haven Hospital — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔